Advertisement
Mucocort receives additional patent approval in China
Mucocort has been granted a patent in China for its product/technology, which has previously been approved under the European Patent System (EPC).
“This approval is a significant step forward in our global growth strategy,” states Jean Lycke, Project Manager at Mucocort.
The Chinese patent secures Mucocort’s technology in one of the world’s largest and most dynamic markets.
”We aim to be a leading global research and development company. This is a crucial component in our IPR portfolio and underscores our commitment to an ambitious IPR and market strategy”, says Lycke.
This product/technology had previously received approval under the European Patent System (EPC). Mucocort is now actively working to extend its patent protection to additional countries, further bolstering the global security of its product.
“We are very proud to have this patent approved in China, a country that is highly significant for both technological innovation and global growth. China is a strategically important market for us, and with this patent, we can effectively safeguard our technology against infringement and enhance our opportunities to form partnerships and alliances within the region,” says Professor Thomas Hedner, Board Member at Mucocort.
Published: October 31, 2024
Advertisement